SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
NEKTAR THERAPEUTICS
@NKTR_InsiderForm 4 Filing: ROBIN HOWARD W Sells $1.2M of $NKTR
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
NEKTAR THERAPEUTICS
Ticker: $NKTR
Transaction Value
$1.2M
Price/Share: $60.75
transaction date
2026-06-17
Shares: 20,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, ROBIN HOWARD W, holds the title of President & CEO at NEKTAR THERAPEUTICS.
On 2026-06-17, the insider transacted 20,000 shares.The shares were transacted at a weighted average price of $60.75 per share, resulting in a total market-relevant value of $1.2M.
Executive Summary Summary
ROBIN HOWARD W (President & CEO) sold $1.2M of $NKTR
Post-Transaction Position: 59,545 shares
SEC Accession No: 0001193125-26-276236 (CIK: 1206869)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.